Mynarix
โ† Back to product catalog
Anti-retroviral Tablet Rx only

Efavirenz Tablets

A non-nucleoside reverse transcriptase inhibitor used in combination for the treatment of HIV-1 infection.

Active ingredient

Efavirenz

Strengths

200, 600 mg

Pack size

30 tablets

ATC class

J05AG03

Indications

Treatment of HIV-1 infection in combination with other antiretroviral agents.

Dosage & administration

600 mg once daily, preferably at bedtime and on an empty stomach to reduce nervous-system effects.

Mechanism of action

Non-competitively inhibits HIV-1 reverse transcriptase, blocking viral replication.

Important safety information

  • May cause dizziness, vivid dreams or mood changes, usually transient.
  • Numerous drug interactions; review concomitant therapy.
  • Avoid in known hypersensitivity.

This page is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Product availability, formulation, and approved indications vary by market. Always consult the approved local labeling and a qualified healthcare professional.